Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock

Annals of Pharmacotherapy

Volumn 46, Issue 3, 2012, Pages

  Dumbarton, Tristan Charles ^a   Gorman, Sean K ^a   Minor, Samuel ^a   Loubani, Osama ^a   White, Fletcher ^b   Green, Robert ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Capital District Health Authority   (Canada)

^c Division of Critical Care Medicine   (Canada)

Author keywords

Methylene blue; Septic shock; Tissue necrosis

Indexed keywords

ADRENALIN; ALANINE AMINOTRANSFERASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; MEROPENEM; METHYLENE BLUE; METHYLPREDNISOLONE; NORADRENALIN; PACLITAXEL; PROPOFOL; VANCOMYCIN; VASOPRESSIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BODY TEMPERATURE; BREATHING RATE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DEBRIDEMENT; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; ENDOTRACHEAL INTUBATION; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FEMALE; FEVER; FLUID RESUSCITATION; HEADACHE; HEART ARREST; HEART RATE; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; INJECTION SITE EXTRAVASATION; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; MEDICAL HISTORY; NAUSEA AND VOMITING; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OVARY CANCER; PNEUMONIA; PRIORITY JOURNAL; RIGOR; SEPTIC SHOCK; SKIN GRAFT; SKIN NECROSIS; STENOTROPHOMONAS MALTOPHILIA; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; TISSUE NECROSIS;

FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIA; METHYLENE BLUE; MIDDLE AGED; NECROSIS; SHOCK, SEPTIC; SKIN; VASOCONSTRICTION;

EID: 84858037556     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q560     Document Type: Article

References (31)

1. Evgenov OV, Bjertnaes LJ. Administration of methylene blue in human septic shock: renaissance of an old drug? Crit Care Med 2003;31:1601-2.
2. Kwok ES, Howes D. Use of methylene blue in sepsis: a systematic review. J Intensive Care Med 2006;21:359-63.
3. Marczin N, Tekeres M, Salzman AL, Szabo C. Methylene blue infusion in septic shock. Crit Care Med 1995;23:1936-8.
4. Scheindlin S. Something old. something blue. Mol Interv 2008;8:268-73.
5. Schirmer RH Coulibaly B, Stich A, et al. Methylene blue as an antimalarial agent. Redox Rep 2003;8:272-5.
6. Gillman K. In reference to parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope 2010; 120:436-7.
7. Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope 2010;119:1941-6.
8. Bradberry SM. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicol Rev 2003;22:13-27.
9. Evora PR, Ribeiro PJ, Vicente WV, et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 2009;24:279-88.
10. Andresen M, Dougnac A, Diaz O, et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care 1998;13:164-8.
11. Brown G, Frankl D, Phang T. Continuous infusion of methylene blue for septic shock. Postgrad Med J 1996;72:612-4.
12. Dumbarton TC, Minor S, Yeung CK, Green R. Prolonged methylene blue infusion in refractory septic shock: a case report. Can J Anaesth 2010;58:401-5.
13. Juffermans NP, Vervloet MG, Daemen-Gubbels CR, et al. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. Nitric Oxide 2010;22:275-80.
14. Koch HJ. Effects of methylene blue in septic shock. Crit Care Med 1996;24:1093-4.
15. Schneider F. Methylene blue infusion in septic shock. Crit Care Med 1995;23:1935-6; author reply 8.
16. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345: 1368-77.
17. Lake C, Beecroft CL. Extravasation injuries and accidental intra-arterial injection. Contin Educ Anaesth Crit Care 2010;10:109-13.
18. Hadaway LC. IV infiltration: not just a peripheral problem. Nursing 2002;32:36-43.
19. Dougherty L. Extravasation: prevention, recognition and management. Nurs Stand 2010;24:48-55.
20. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs 2006;29:1-S92.
21. Menardi AC, Viaro F, Vicente WV, Rodrigues AJ, Evora PR. Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue. Arq Bras Cardiol 2006;87: 525-32.
22. Passow H, Rothstein A, Loewenstein B. An all-or-none response in the release of potassium by yeast cells with methylene blue and other basic redox dyes. J Gen Physiol 1959;43:97-107.
23. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 2002; 184:350-2.
24. Methelene blue. In: DRUGDEX system [Internet database]. Thompson Healthcare. Updated periodically; 2011.
25. Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995;23:259-64.
26. Ruhlen JL. Tissue necrosis. Cutaneous and subcutaneous damage following extravasation of methylene blue. J Kans Med Soc 1982;83:236-60.
27. Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 2001;29:1860-7.
28. Perry PM, Meinhard E. Nectotic subcutaneous abscesses following injections of methylene blue. Br J Clin Pract 1974;28:289-91.
29. Bleicher RJ, Kloth DD, Robinson D, Axelrod P. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 2009;99:356-60.
30. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189:236-9.
31. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.